PANCREATIC ONCOLOGY · CONDITION GUIDE
Pancreatic Neoplasm
Tumours of the pancreas — ranging from resectable adenocarcinoma to benign endocrine tumours — requiring precise surgical resection as part of a multidisciplinary oncological treatment plan.
ABOUT THIS CONDITION
What is Pancreatic Neoplasm?
Pancreatic neoplasms encompass a wide spectrum of tumours — pancreatic ductal adenocarcinoma (the most common and aggressive), pancreatic neuroendocrine tumours (PNETs), intraductal papillary mucinous neoplasms (IPMNs), mucinous cystadenomas, and solid pseudopapillary tumours. Surgical resection offers the only chance of cure for resectable malignancies and is indicated for symptomatic or high-risk benign tumours. Dr. Tagore Mohan Grandhi performs pancreatic resection at Lux Hospitals, Hyderabad, as part of a multidisciplinary hepatopancreaticobiliary (HPB) team. The operation — Whipple’s procedure, distal pancreatectomy, or tumour enucleation — is determined by tumour location, histological type, and proximity to the main pancreatic duct and vascular structures.
SIGNS TO WATCH
Common Symptoms
Symptoms that need attention
WHY IT HAPPENS
Causes & Risk Factors
- Pancreatic ductal adenocarcinoma — associated with smoking, diabetes, and chronic pancreatitis
- KRAS, CDKN2A, SMAD4, and TP53 gene mutations in adenocarcinoma
- Hereditary syndromes — BRCA2, Lynch syndrome, Peutz-Jeghers increasing lifetime risk
- Familial pancreatic cancer in first-degree relatives
- Pancreatic neuroendocrine tumours from islet cell dysplasia — often sporadic
- IPMN progression from mucinous ductal neoplasm to invasive carcinoma
CLINICAL DETAILS
KeyFacts
Whipple’s procedure (pancreaticoduodenectomy)
Distal pancreatectomy with or without splenectomy
Enucleation to preserve pancreatic parenchyma
CT and MRI assess vascular involvement before surgery
Up to 20–25% for resected pancreatic adenocarcinoma
Available at Lux Hospitals, Hitech City, Hyderabad
HOW WE TREAT IT
Treatment Approach
Multidisciplinary HPB Team
Pancreatic neoplasms require meticulous pre-operative staging, expert surgical technique, and structured post-operative oncological follow-up. Dr. Grandhi works within a dedicated HPB multidisciplinary team including hepatology, oncology, interventional radiology, and nutrition to optimise outcomes at every stage of the treatment pathway.
- 1
Staging & Resectability Assessment
High-quality pancreatic protocol CT and MRI assess tumour size, vascular involvement, lymph nodes, and distant metastases. EUS with biopsy provides tissue diagnosis. Staging laparoscopy excludes peritoneal disease.
- 2
MDT Planning & Neoadjuvant Therapy
The MDT determines resectability and the role of neoadjuvant chemotherapy for borderline resectable or locally advanced tumours. PNETs and cystic neoplasms are planned for direct resection.
- 3
Surgical Resection
Whipple’s procedure for head tumours; distal pancreatectomy for body/tail tumours; enucleation for small benign lesions. Vascular reconstruction is performed where superior mesenteric or portal vein involvement necessitates resection.
- 4
Post-operative Recovery & Oncology
PERT supplementation commenced. Adjuvant chemotherapy planned by MDT. Surveillance imaging at regular intervals. Dietetic support and diabetic management maintained throughout.
AVAILABLE TREATMENTS
TreatmentOptions
Whipple’s Procedure (Pancreaticoduodenectomy)
Resection of the pancreatic head, duodenum, bile duct, and gallbladder with reconstruction. Standard procedure for tumours of the pancreatic head and periampullary region.
Distal Pancreatectomy
Resection of the pancreatic body and tail, usually with splenectomy. Performed for tumours of the body and tail of the pancreas.
COMMON QUESTIONS
Frequently Asked Questions
Not sure about your condition?
Compassionate, confidential consultations — Book your appointment today.